Bausch Health reports better Q2 results, raises 2019 earnings forecast

LAVAL, Que. — Bausch Health Companies Inc. slightly missed earnings estimates in the second quarter even as it nudged up its full-year forecast Tuesday on better results.

Chief executive Joseph Papa said he expects Bausch — formerly known as Valeant Pharmaceuticals — will generate between US$8.4 billion and US$8.6 billion in revenue this year, about US$50 million more than its previous outlook.

Bausch, which reports in U.S. dollars, also raised its adjusted EBITDA (earnings before interest, taxes and other items) range by $25 million to between $3.43 billion and $3.58 billion.

“Our strong second-quarter results demonstrate that our team’s efforts to pivot to offence continue to gain traction,” Papa said on a conference call, citing three per cent organic revenue growth in the second quarter compared with the same period last year.

He reiterated his forecast that Bausch, which has shifted away from an aggressive acquisition strategy to focus on slashing debt since Papa took the helm in 2016, will double annual revenue from its seven major products to roughly $300 million.

The so-called “significant seven,” which include optical products that treat conditions ranging from glaucoma to bloodshot eyes, rose 76 per cent in the first half of 2019 to drive overall sales growth.

Bausch chopped its debt by about $100 million in the quarter ended June 30, shrinking total debt by 0.4 per cent year-over-year to $24.37 billion.

Headquartered in Laval, Que., Bausch has spent the past few years mired in investigations and lawsuits, including antitrust litigation and a fraud probe in California.

Those efforts have resulted in the settlement or dismissal of about 60 cases as of the end of last year, with most of the legal issues now resolved, according to a spokeswoman.

The company said its second-quarter net loss attributable to shareholders was $170 million, reduced from $872 million a year earlier.

Bausch attributed the improvement to better operating results, lower interest expenses and a smaller loss on debt repayments.

The net loss amounted to 49 cents per share, down from $2.49 per share in last year’s second quarter.

Adjusted EBITDA improved to $880 million from $868 million a year earlier while adjusted net earnings were $372 million, up from $327 million a year ago.

Bausch’s second-quarter revenue was $2.15 billion, up one per cent from a year earlier due to its New Jersey-based Salix subsidiary, which develops prescription drugs and medical devices aimed at gastrointestinal disorders.

Analysts had estimated $2.14 billion of revenue but $889.7 million in EBITDA and $377 million in adjusted net income, according to financial markets data firm Refinitiv.

Bausch’s shares lost $1.56 or nearly five per cent to close at $30 Tuesday on the Toronto Stock Exchange.

Just Posted

Expert panel to review supervised consumption sites in Alberta including Red Deer

Eight experts will hear from Albertans on the social and economic impacts… Continue reading

Environment groups warned saying climate change is real could be seen as partisan

OTTAWA — A pre-election chill has descended over some environment charities after… Continue reading

Scheer repeats call on RCMP to investigate Trudeau’s actions in SNC affair

OTTAWA — Conservative Leader Andrew Scheer says the federal ethics commissioner’s stinging… Continue reading

Vikings Days a celebration of Danish immigration, culture

The Danish Canadian Museum near Dickson held its annual Viking Days celebration… Continue reading

WATCH: ‘Lots to see and do’ at Pioneer Days in Red Deer

Sunnybrook Farm Museum is celebrating its 24th annual Pioneer Days this weekend.… Continue reading

Your community calendar

Thursday The Red Deer and District Garden Club hosts its annual Flower… Continue reading

34% of economists in survey expect a US recession in 2021

WASHINGTON — A number of U.S. business economists appear sufficiently concerned about… Continue reading

Ontario cannabis retailer returns $2.9M in CannTrust products to company

VAUGHAN, Ont. — CannTrust Holdings Inc. says the Ontario government’s cannabis retailer… Continue reading

Pipeline rupture sends 40,000 litres of oil into Alberta creek

DRAYTON VALLEY, Alta. — The Alberta Energy Regulator says a pipeline has… Continue reading

Chrystia Freeland condemns violence in Hong Kong, backs right to peaceful assembly

OTTAWA — Foreign Affairs Minister Chrystia Freeland has condemned violence in Hong… Continue reading

Turtles, butterflies and foxes: Captive breeding for endangered species growing

LANGLEY, B.C. — The turtle in my hand dangles its churning feet… Continue reading

Saskatoon Cubs win Westerns with wild extra-innings comeback

The Saskatoon Cubs showed no quit in the finals of the 18UAAA… Continue reading

Canada ‘disappointed’ terror suspect’s British citizenship revoked

OTTAWA — The United Kingdom is shirking its share of the international… Continue reading

Most Read